Fixing Gene Therapy Access With AI | How Genoplex Is Helping Patients Get Treated Faster #genetherapy #biotech #healthcareaiWhat if gene therapy could cure your disease, but you never made it to the treatment center in time? In this episode of Biotech Bytes, we dive into that real and urgent problem with Christopher Leidli, CEO of Genoplex.ai. Chris shares how his company uses AI to match patients with advanced therapies and treatment centers faster than ever before. Please visit our website to get more information: https://swangroup.net/ We talk about the logistics, the outdated systems, and the patient pain points that make accessing cutting-edge gene and cell therapies so difficult. From working at biotech giants like Amgen and J&J to launching a startup to bridge the access gap, Chris has seen every side of this challenge.You'll learn the difference between gene therapy, cell therapy, and T-cell therapy, the current FDA-approved treatments, and why health equity is still a major barrier. We also get into how Genoplex’s platform works and why AI could be the key to helping patients get lifesaving care when it matters most.🔔𝐃𝐨𝐧'𝐭 𝐟𝐨𝐫𝐠𝐞𝐭 𝐭𝐨 𝐬𝐮𝐛𝐬𝐜𝐫𝐢𝐛𝐞 𝐭𝐨 𝐨𝐮𝐫 𝐜𝐡𝐚𝐧𝐧𝐞𝐥 𝐟𝐨𝐫 𝐦𝐨𝐫𝐞 𝐮𝐩𝐝𝐚𝐭𝐞𝐬.https://www.youtube.com/@Biotech_Bytes/?sub_confirmation=1 🔗 Stay Connected With Us.Linkedin: https://www.linkedin.com/company/the-swan-group/ Website: https://swangroup.net/ =============================🎬Suggested videos for you:▶️ https://www.youtube.com/watch?v=NQN6X206A94 ▶️ https://www.youtube.com/watch?v=ZWXIIe66-kI ▶️ https://www.youtube.com/watch?v=_Be6WEEy2JM ▶️ https://www.youtube.com/watch?v=mqpB3pGywkU ▶️ https://www.youtube.com/watch?v=w9QyuG6p3Ys=============================✅ About Biotech Bytes by The Swan Group.Welcome to The Swan Group’s Pharmaceutical Industry Podcast Biotech Bytes: Conversations with Biotechnology / Pharmaceutical IT Leaders, where expertise meets innovation at a crossroads in the pharma and life sciences. With over four decades of rich industry history, our podcast delves into the critical topics and trends shaping the pharmaceutical landscape. Each episode brings insights from industry leaders, discussions on best practices, and an in-depth look at the strategies driving success in the life sciences sector.Join us as we explore the pulse of pharma through the lens of The Swan Group’s extensive network and specialized recruitment know-how.🔔 Unlock the secrets of pharma success—subscribe for expert tips, industry leader interviews, innovative strategies, and revolutionary trends!https://www.youtube.com/@Biotech_Bytes/?sub_confirmation=1 =================================🔎 Related Phrases:Fixing Gene Therapy Access With AI, How Genoplex Is Helping Patients Get Treated Faster, How Genoplex Helps Patients Find Treatment, Gene And Cell Therapy Explained, Difference Between Gene And Cell Therapy, Why Patients Can't Access Gene Therapy, How Ai Is Transforming Healthcare Access, Fda Approved Gene Therapy Drugs 2025, Using Ai For Medical Referrals, Health Equity In Biotech, Gene Therapy For Sickle Cell Disease#genetherapy #biotech #

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.